Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 138261000087110 | RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 22391000087119 | Rota RotaTeq MC | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 22411000087119 | RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 77001000087111 | Rota RotaTeq MC | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug) | est un(e) (attribut) | Vaccine product containing only Rotavirus 5 serotypes antigens (medicinal product) | true | Inferred relationship | Some | ||
| RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug) | a pour principe actif (attribut) | Antigen of live attenuated human-bovine reassortant Rotavirus serotype G1 (substance) | true | Inferred relationship | Some | 2 | |
| RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug) | a pour principe actif (attribut) | Antigen of live attenuated human-bovine reassortant Rotavirus serotype G3 (substance) | true | Inferred relationship | Some | 4 | |
| RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug) | Has supplier | Merck Canada Inc. (supplier) | true | Inferred relationship | Some | ||
| RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug) | a pour principe actif (attribut) | Antigen of live attenuated human-bovine reassortant Rotavirus serotype G4 (substance) | true | Inferred relationship | Some | 5 | |
| RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug) | est un(e) (attribut) | Vaccine product containing only live attenuated Rotavirus antigen (medicinal product) | true | Inferred relationship | Some | ||
| RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug) | Count of active ingredient | cinq | false | Inferred relationship | Some | ||
| RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug) | a une forme pharmaceutique (attribut) | forme orale | true | Inferred relationship | Some | ||
| RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug) | a pour principe actif (attribut) | Antigen of live attenuated human-bovine reassortant Rotavirus serotype P1A[8] (substance) | true | Inferred relationship | Some | 1 | |
| RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug) | a pour principe actif (attribut) | Antigen of live attenuated human-bovine reassortant Rotavirus serotype G2 (substance) | true | Inferred relationship | Some | 3 | |
| RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug) | est un(e) (attribut) | Product manufactured as oral dose form (product) | true | Inferred relationship | Some | ||
| RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug) | a pour principe actif (attribut) | Rotavirus vaccine (substance) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Canada English language reference set (foundation metadata concept)
Administered tradename codes for vaccines reference set (foundation metadata concept)
Description inactivation indicator reference set
FHIR